#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Colon cancer Malignant melanoma Hepatitis D PIK3CA-activated mutation Activated PI3 kinase delta syndrome Hormone-dependent prostate cancer Short stature homeobox gene mutation Huntington's disease Essential thrombocythaemia Liver transplant rejection Ureteric cancer Chemical burn Immunodeficiency common variable Hypertriglyceridaemia Haemophilia A with anti factor VIII More trials…

    Learn about Rare Diseases

    Medulloblastoma recurrent – Treatment Leiomyosarcoma Optic glioma – Trials in Disease Lennox-Gastaut syndrome – Life with Disease Breast angiosarcoma metastatic Phenylketonuria – Trials in Disease Glycogen storage disease type II – Life with Disease Sarcoma – Diagnostics Prader-Willi syndrome – Basic Information Osteosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ibrexafungerp Colchicine Estriol (-)-PHENSERINE TARTRATE Danazol Ublituximab Vb10.16 Cefepime Hydrochloride Gskvx000000008885 Gemcitabine Hydrochloride Exl01 Semaglutide Clenbuterol Hydrochloride Mps-112 Vibegron Acoramidis Hydrochloride Gr0015 Other Immunosuppressants Levonorgestrel VRDN-003 More therapies…

    Learn about Your Condition

    Rheumatoid arthritis Peripheral artery angioplasty Hydrocephalus Deafness neurosensory Glomerulonephritis acute Osteomyelitis Varicella Pancreatic neoplasm Chronic spontaneous urticaria Bladder cancer Endocrine ophthalmopathy Thrombocytopenia Injection site pain Bronchopulmonary aspergillosis Oral herpes More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Small cell lung cancer extensive stage

  • A study to evaluate the effectiveness of tarlatamab in patients with extensive-stage small cell lung cancer that has progressed after prior treatment and who have limited health status

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Small cell lung cancer
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Tarlatamab
    France Greece Italy Spain

  • A study of PF-08634404 and a drug combination for adult patients with extensive-stage small cell lung cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Carboplatin
    • Etoposide
    France Germany Italy Spain

  • Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    • Small cell lung cancer extensive stage
    • Small cell lung cancer metastatic
    Investigated Drugs:
    • BNT327
    • Atezolizumab
    • Carboplatin
    France Germany Italy The Netherlands Poland Romania +1

  • Testing Tarlatamab in Patients with Advanced Small-Cell Lung Cancer Who Have Poor Physical Condition

    Recruiting

    2 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    • Small cell lung cancer metastatic
    Investigated Drugs:
    • Tarlatamab
    Germany

  • Study Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Sacituzumab Govitecan
    • Topotecan
    Belgium France Germany Greece Hungary Italy +5

  • Study Comparing BMS-986489 with Chemotherapy to Atezolizumab with Chemotherapy for First-Line Treatment in Patients with Extensive-Stage Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Atezolizumab
    • ATIGOTATUG
    • Carboplatin
    Austria Belgium Czechia France Germany Greece +5
1 2 3 … 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!